Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Hlavní autor: | Tania, Umme |
---|---|
Další autoři: | Haque , Md. Aminul |
Médium: | Diplomová práce |
Jazyk: | en_US |
Vydáno: |
Brac University
2021
|
Témata: | |
On-line přístup: | http://hdl.handle.net/10361/15111 |
Podobné jednotky
-
Biosimilar in lymphoma treatment
Autor: Tanisha, Mehrin Haque
Vydáno: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
Autor: Tabassum, Turana
Vydáno: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Autor: Tania, Umme
Vydáno: (2023) -
Advancement of Antibody-Drug conjugates in cancer treatment: A review
Autor: Sagar, Baejid Hossain
Vydáno: (2022) -
Immunotherapeutic approaches to treat cancer: Prospects and challenges
Autor: Fred, Namanda Rogers
Vydáno: (2021)